NCT06482411Completed
Risk Factors Affect Weight Loss Outcomes After Treatment.
Exploration of Effect Weight Loss Outcome Related to Factors After Treatment of Weight Loss (WRRFA).
Source: ClinicalTrials.gov · Last updated 6 Jan 2026
Brief summary (registry, in English)
The treatment for weight loss was more diverse due to the higher prevalence of obesity. In addition to weight loss medications, many patients seek bariatric surgery to treat obesity. Although bariatric surgery was the most effective way, the patients still get weight gain due to failure to control their lives. The failure weight loss is caused by complex risk factors, such as dietary habits, quality of life, physical inactivity, comorbidities remission rate, and more related to the failure weight loss factors. To explore weight gain factors, the study uses many questionnaires, including demographic parameter and exercise frequency survey, the WHOQOL-BREF assessment, The Bariatric Quality of Life Questionnaire (BQL), the Three-Factor Eating Questionnaire (TFEQ-R18), the Yale Food Addiction Scale version 2.0 (YFAS 2.0), and Depression Anxiety Stress Scales-21 (DASS-21). The investigators assess different factors like quality of life, food addiction, preferences, psychological status, and regular examination parameters to identify reasons for unsuccessful weight loss. The study aims to establish the model for the prediction of risk factors after treatment of weight loss so that the tools will help to manage the best weight control for the future.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 3602 (actual)
- First submitted
- 17 Jun 2024
- Start date
- 27 Jun 2024
- Primary completion date
- 22 Oct 2025
- Lead sponsor
- E-DA Hospital
- Diseases
- Obesity
- NCT number
- NCT06482411
What you commit to
- Study type: Observational
- Participants enrolled: 3602
- From 27 Jun 2024 to the primary completion date, 22 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Inclusion 1.65 ≥ Age ≥ 20 years-old. 2.BMI ≥ 30. 3.Once attempted exercise or dietary control. 4.No cognitive deficiency and clear communication. 5. No severe psychotic disorders were evaluated by the psychiatrist. (e.g. schizophrenia, bipolar disorder, or severe depression).
- 6\. Signing the informed consent form for clinical trials.
- Exclusion
- Once underwent bariatric surgery.
- Once used the GLP-1 receptor agonist.
- Pregnancy or preparation for pregnancy.
- Once and presenting gastric cancer.
- Presenting the other cancer.
- The abnormal endocrine system causes diseases with obesity.
- Major organ abnormalities (e.g., kidney failure, liver failure, heart failure, etc.).
- Gastric ulcer, and severe gastroesophageal reflux.
- Severe psychiatric disorders (schizophrenia, severe bipolar disorder, and depression, etc.).
- Bulimia nervosa or anorexia nervosa.
- Drug and alcohol abuse.
- Helicobacter pylori is not for bariatric surgery.
- The following diseases or conditions preclude the use of Contrave: 1)Uncontrolled hypertension, 2) History or current diagnosis of epilepsy, 3) Allergy to this medication, 4) Medications evaluated by a physician to interact with this drug (antidepressants, antipsychotics, liver medications, heart medications).
- The following diseases or conditions preclude the use of GLP-1 medication: 1) History or current diagnosis of medullary thyroid carcinoma, 2)History or current diagnosis of Multiple Endocrine Neoplasia syndrome type 2, 3)Allergy to this medication, 4)Medications evaluated by a physician to interact with this drug (antidepressants, antipsychotics, liver medications, heart medications).
- The following diseases or conditions preclude the use of Xenical medication: 1) History or current diagnosis of cholestasis, 2) Allergy to this medication, 3) Medications evaluated by a physician to interact with this drug (antidepressants, antipsychotics, liver medications, heart medications).
Age in the registry: 20 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chung-Yen Chen Coordinator of this site? Confirm its status | Kaohsiung City | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.